Alle reden über Shionogi & Co Ltd – aber lohnt sich der ...

Hype um Shionogi & Co Ltd: Pharma-Geheimtipp wird plötzlich zum Börsen-Star

Wiens Seestadt Aspern baut ihr Angebot an modernen Gewerbeflächen ...

Seestadt Aspern baut Produktionsflächen für Start-ups aus

Evotec SE positioniert sich als vollintegrierte Wirkstofffabrik: ...

Evotec SE: Wie der Plattform-Spezialist die Medikamentenentwicklung industrialisiert

Die Takeda Pharmaceutical Co Ltd steht nach Kursrückschlag ...

Takeda-Aktie zwischen Dividendencharme und Pipeline-Risiken: Wie attraktiv ist der japanische Pharmariese jetzt?

Takeda looks boring on the surface but the stock the pipeline ...

The Truth About Takeda Pharmaceutical Co Ltd: Is This Pharma Giant a Silent Market Cheat Code?

Halozyme Therapeutics US40637H1095

Halozyme’s Strategic Partnership Meets Market Skepticism

UCB S.A. positioniert sich vom klassischen Pharmahersteller ...

UCB S.A.: Wie der Biotech-Spezialist mit Bimzelx, Fintepla & Co. zur Plattform für Immun- und Hirnerkrankungen wird

Grifols S.A. is betting big on plasma?derived therapies ...

Grifols S.A.: How a Plasma Powerhouse Is Re?engineering the Biotech Playbook

Pharma-Aktie im Fokus: Otsuka Holdings Co Ltd wird zum Netz-Geheimtipp. ...

Hype um Darum reden jetzt alle über die Pharma-Aktie

Takeda Pharmaceutical’s stock has been treading water ...

Takeda’s Stock Under the Microscope: Quiet Drift, Subdued Optimism, And A Market Waiting For A Catalyst

Everyone’s sleeping on Takeda Pharmaceutical Co Ltd but ...

The Truth About Takeda Pharmaceutical Co Ltd: Is This Pharma Giant a Hidden Power Play for Your Portfolio?

Takeda and Protagonist Announce Submission of New Drug Application for Rusfertide for Treatment of Polycythemia Vera

Sensei Biotherapeutics erlebt nach einer Lizenzvereinbarung ...

Sensei Biotherapeutics: Kleine Krebsforscherin, großer Kurssprung – wie nachhaltig ist die Rallye der SNSE-Aktie?

Grifols S.A. is doubling down on plasma-derived therapies ...

Grifols S.A.: How a Plasma Powerhouse is Rebooting Its Future

Astellas Pharma Inc geht an der Börse und auf Social Media ...

Hype um Astellas Pharma Inc: Warum jetzt alle über den Pharmariesen sprechen – und was du davon hast

Die Takeda-Aktie bleibt ein defensiver Pharmatitel mit solider ...

Takeda Pharmaceutical Co Ltd: Defensive Pharma-Aktie zwischen Dividendenstabilität und Pipeline-Druck

Kyowa Kirin Co Ltd is not on your FYP yet but its stock ...

The Truth About Kyowa Kirin Co Ltd: Quiet Pharma Stock That Might Be a Sneaky Power Play

Grifols S.A. is betting on industrial-scale plasma science ...

Grifols S.A.: Can a Plasma Powerhouse Reinvent Itself as a Next?Gen Biotech Platform?

Everyone is suddenly talking about Grifols S.A. after a ...

Grifols S.A. Just Broke Your Portfolio’s Brain: Bargain, Trap, or Sneaky Comeback Play?

Takeda looks boring on the surface but the money moves behind ...

The Truth About Takeda Pharmaceutical Co Ltd: Is This Pharma Giant a Sneaky Power Play for Your Portfolio?

Sanofi S.A. richtet sein Geschäftsmodell radikal auf innovative ...

Sanofi S.A.: Wie der Pharmakonzern sein Portfolio für die Ära von KI-Medikamenten und Blockbuster-Impfstoffen schärft

Die Takeda Pharmaceutical (ADR) steht an der Wall Street ...

Takeda Pharmaceutical (ADR): Defensiver Pharma-Riese zwischen Kursdruck und Dividendenstärke

Takeda's Zasocitinib Landmark Phase 3 Plaque Psoriasis Data Show Promise to Deliver Clear Skin in a Once-Daily Pill, Catalyzing a New Era of Treatment

Die Aktie des chinesischen Biotech-Unternehmens verlor deutlich ...

Innovent Biologics Aktie: Paradoxe Reaktion

Protagonist Therapeutics US74366E1029

Protagonist Therapeutics Shares Trade Above Analyst Consensus

Takeda Presents New Data Showing Mezagitamab Sustained Effect on Kidney Function 18 Months After Treatment in Primary IgA Nephropathy

HKSTP Crowns EPIC 2025 Winner: Champion of HKSTP EPIC 2025 ...

HKSTP

NDR: Dreh für zwei neue Kieler „Tatort“-Krimis mit ...

NDR: Dreh für zwei neue Kieler „Tatort“-Krimis mit Almila Bagriacik und Karoline Schuch, Episodenrollen: Jutta Speidel und Franziska Hartmann

HKSTP Manifesting 20 Latest BFSI Tech and Translation of ...

HKSTP

Takeda Reports First Half FY2025 Results with Business Fundamentals Tracking as Planned. Updates Full Year Outlook to Reflect FX Impact and Pipeline Impairment. On Track for ...

Takeda Pharmaceutical Company Limited: Notice of the Revised ...

Takeda Pharmaceutical Company Limited / JP3463000004

EQS-News: TetraScience startet wissenschaftliches KI-Leuchtturmprogramm ...

TetraScience startet wissenschaftliches KI-Leuchtturmprogramm mit Takeda als Gründungspartner EQS-News: TetraScience / Schlagwort(e): Produkteinführung TetraScience startet ...

TetraScience startet wissenschaftliches KI-Leuchtturmprogramm ...

TetraScience

TetraScience Launches Scientific AI Lighthouse Program with ...

TetraScience

GNW-News: Nilo Therapeutics startet mit einer Serie-A-Finanzierung ...

NEW YORK, Oct.

20,000 + Takeda Employees Voted to Select Four New Global Corporate Social Responsibility Collaborations to Advance Climate-Resilient Health Systems in 94 Countries

Das Biopharma-Unternehmen stellt aktualisierte Studienergebnisse ...

Hutchmed Aktie: Klinische Daten im Fokus

U.S. FDA Approves Expanded Indication for VONVENDI? [von Willebrand factor ] for Adults and Children with Von Willebrand Disease

Top 100 Semi-Finalists Set Sail for EPIC 2025 Grand Finale ...

Hong Kong Science and Technology Parks Corporation

Advanced Therapies Europe 2025 unveils a reimagined high-impact ...

Advanced Therapies Europe Austria Belgium France Germany Italy Netherlands Spain Switzerland United Kingdom

NANOFORM COLLABORATES WITH TAKEDA ON THEIR PLASMA-DERIVED ...

Nanoform Finland

La Agencia Europea de Medicamentos aprueba una opción adicional ...

Takeda Austria Belgium France Germany Italy Netherlands Spain Switzerland United Kingdom

L Agence européenne des médicaments a approuvé une option supplémentaire d ...

Takeda Austria Belgium France Germany Italy Netherlands Spain Switzerland United Kingdom

Skyhawk Therapeutics se dote de laboratoires ultramodernes ...

Skyhawk Therapeutics Switzerland Massachusetts

Metastatic Prostate Cancer Market to Exhibit Positive Growth ...

DelveInsight Business Research, LLP United States of America United Kingdom

Biopharma Leaders Unite to Shape the Future of Customer-Centric ...

Veeva Systems Spain New Jersey

The European Medicines Agency Has Approved an Additional ...

Takeda Austria Belgium France Germany Italy Netherlands Spain Switzerland United Kingdom

Regenerative Medicine Market Worth $49.0 Billion | MarketsandMarkets™. ...

MarketsandMarkets United Kingdom United States of America

Skyhawk Therapeutics Expands into State-of-the-Art Labs ...

Skyhawk Therapeutics Massachusetts Switzerland

Immunotherapy Drugs Market worth $580.6 billion by 2029 ...

MarketsandMarkets United States of America United Kingdom

Regenerative Medicine Market to Reach $45.66 Billion by ...

Meticulous Market Research Pvt. Ltd. United States of America United Kingdom California

Aquinnah Pharmaceuticals Advances Oral Small Molecule Program ...

Aquinnah Pharmaceuticals Massachusetts

Vaccines Market to be Worth $71.50 billion in 2031- Exclusive ...

Meticulous Market Research Pvt. Ltd. United States of America United Kingdom

Ascentage Pharma Announces Closing of US$75 Million Equity ...

Ascentage Pharma China Maryland

Colorectal Cancer Treatment Market Size is Projected to ...

The Insight Partners United States of America United Kingdom

Generalized Anxiety Disorder Treatment Market to Showcase ...

DelveInsight Business Research, LLP United Kingdom United States of America California

Empathy in Action: Takeda's Global Initiative Brings IBD ...

Empathy in Action: Takeda's Global Initiative Brings IBD Challenges to the Forefront in the UAE

The European Commission Approves Label Update for TAKHZYRO® ...

Takeda Austria Belgium France Germany Italy Netherlands Spain Switzerland United Kingdom

Global Gastroparesis Treatment Market is Expected to Grow ...

Infinium Global Research United Kingdom United States of America

Alpha-1 Antitrypsin Deficiency Market to Register Incremental ...

DelveInsight Business Research, LLP United States of America United Kingdom Ireland

Psoriasis Market to Register Incremental Growth by 2034 ...

DelveInsight Business Research, LLP United States of America United Kingdom

Regenerative Medicine Market to Reach $37.27 Billion by ...

Meticulous Market Research Pvt. Ltd. United States of America United Kingdom

Merkel Cell Carcinoma Market to Grow Rapidly at a CAGR of ...

DelveInsight Business Research, LLP United States of America United Kingdom

Chronic Inflammatory Demyelinating Polyneuropathy Market ...

DelveInsight Business Research, LLP United States of America United Kingdom Ireland

Die Europäische Arzneimittelagentur hat eine zusätzliche ...

Takeda Austria Belgium France Germany Italy Netherlands Spain Switzerland United Kingdom

Uveitis Treatment Market Size is Estimated at $1.4 Billion ...

Fact.MR United States of America United Kingdom

Next Generation Complement Therapeutics Market worth $23.04 ...

InsightAce Analytic Pvt. Ltd United States of America United Kingdom

Nísia: Brasil vai ampliar oferta de doses contra a dengue ...

Brazil Nigeria

Takeda erhält FDA-Zulassung gemäß 510 für HyHubTM und ...

Takeda ( TSE:4502/NYSE:TAK ) gab heute bekannt dass die US-amerikanische Arzneimittelbehörde FDA (Food and Drug Administration) die 510(k)-Zulassung für HyHubTM und HyHubTM ...

Polpharma Biologics and Fresenius Kabi Sign Licensing Agreement for Proposed Vedolizumab Biosimilar PB016

Takeda Announces First-Quarter FY2025 Results With Significant Late-Stage Pipeline Progression

Takeda Announces Positive Results from Two Pivotal Phase 3 Studies of Oveporexton in Narcolepsy Type 1

Takeda Announces New Assignments of Directors

Protagonist and Takeda Announce ASCO Plenary Presentation Highlighting Full 32-Week Results from Phase 3 VERIFY Study of Rusfertide Showing Reductions in Phlebotomy Improved ...

Takeda and Nature Announce Call for Applications Now Open ...

Takeda and Nature Announce Call for Applications Now Open for 2026 Innovators in Science Award

JCB partners with PayXpert to expand in-store card acceptance ...

Tokyo London and Paris May 27 2025 - (JCN Newswire) - JCB and PayXpert a pioneering omnichannel payment services provider based in Europe and in the UK today announced a strategic ...

The New England Journal of Medicine Publishes Data from Phase 2b Trial of Oral Orexin Receptor 2 Agonist Oveporexton in People with Narcolepsy Type 1

Takeda Announces FY2024 Full Year Results and FY2025 Outlook Reflecting Growth & Launch Products Momentum, Strong Cash Flow Generation and Late-Stage Pipeline Progress

FW Stockach: Brand einer Absauganlage in einem holzverarbeitenden ...

Stockach - Wahlwies - Am 30.04.2025 um 13:03 Uhr wurde die Feuerwehr Stockach mit den Abteilungen Wahlwies Espasingen und Kernstadt mit dem Alarmstichwort B3 - Feuer in Gebäude ...

XORTX veröffentlicht Update zur Anfrage der FDA zum Typ-B-Meeting ...

XORTX Therapeutics Inc. / CA98420Q3061

XORTX gibt Erteilung eines europäischen Patents bekannt ...

XORTX Therapeutics Inc. / CA98420Q3061

FW Stockach: Übungswochenende Roter Heuberg 2025 auf dem ...

Stockach - Ein intensives Übungswochenende erlebten Feuerwehren aus ganz Baden-Württemberg der Schweiz und Liechtenstein sowie zwei Fahrzeuge der Bundeswehr auf dem Truppenübungsplatz ...

JCB and First Cash Solution Partner to Help Cardmembers ...

Tokyo London and Frankfurt Mar 18 2025 - (JCN Newswire) - JCB Japan's only international payment brand and First Cash Solution a leading integrated payment provider as a subsidiary ...

KI-gestützte Analysen könnten die neurologische Therapie ...

FireFly-KI-Tool soll Wirksamkeit von Hemostemix‘ ACP-01-Therapie bei Demenz objektiv prüfen

Protagonist and Takeda Announce Positive Topline Results from Phase 3 VERIFY Study of Rusfertide in Patients with Polycythemia Vera

XORTX initiiert Gichtprogramm und NDA-Gespräche mit der ...

XORTX Therapeutics Inc. / CA98420Q3061

Stretto Inc., Fujimi Incorporated, and SBI Life with NuSummit Win Findability Sciences Global AI Awards 2025 for Pioneering AI-Driven Transformation

Celebrating the Legacy of Excellence and Innovation. Zydus ...

Celebrating the Legacy of Excellence and Innovation

Takeda Pharmaceutical Company Limited: Julie Kim Will Succeed ...

Takeda Pharmaceutical Company Limited / JP3463000004

Takeda Delivers Strong Third-Quarter FY2024 Results; Raises Full Year Outlook, Forecasting Revenue and Core Operating Profit Margin Growth

Julie Kim Will Succeed Christophe Weber as CEO of Takeda in June 2026

Zelltherapien erfreuen sich einer immer größeren Beliebtheit. ...

Weltweiter Markt für Zelltherapie soll bis 2034 jährlich um 20% wachsen

JCB and DOJO partner to help cardmembers enjoy a more seamless ...

TOKYO & LONDON Jan 16 2025 - (JCN Newswire) - JCB Japan s only international payment brand, and DOJO, a London-based payment technology provider, today announced a strategic partnership to enhance JCB ...

JCB unveils a new e-book that empowers merchants and acquirers ...

JCB unveils a new e-book that empowers merchants and acquirers to harness growth drivers in the European region

Top 25 Best Places to Work in Europe for 2024 revealed

Best Places to Work

XORTX fügt seiner Pipeline ein Programm der Spätphase ...

XORTX Therapeutics Inc. / CA98420Q3061

Takeda Announces Approval of HYQVIA? 10% S.C. Injection Set in Japan for Patients with Agammaglobulinemia or Hypogammaglobulinemia

Takeda Spotlights High-Value, Late-Stage Pipeline Accelerating the Development of Potential Transformative Treatments for Patients in Multiple Therapeutic Areas

Blackstone Announces Acquisition of Tokyo Garden Terrace Kioicho, Japan?s Largest Ever Real Estate Investment by a Foreign Investor

JCB to Enable Seamless Transactions on ETA Applications ...

TOKYO & LONDON Dec 12 2024 - (JCN Newswire) - JCB International Co Ltd the international operations subsidiary of JCB Co Ltd Japan's only international payment brand today ...